Yaz, Yasmin and Ocella News

We have compiled the latest news on Yas, Yazmin and Ocella. If you or a loved one has been harmed by one of these drugs and you would like more information about your legal rights, please contact us.

Units of Bayer AG (BAYN), Germany’s largest drugmaker, may have sought to market the Yasmin family of birth- control pills for unapproved uses and misled women about the health risks the drug posed, according to company e-mails.

Bayer unit officials discussed promoting the contraceptive known as Yaz, a spinoff of Yasmin, for treatment of all types of premenstrual syndrome, according to company files provided to lawyers for women suing Bayer. U.S. regulators approved Yaz only for the most severe form of PMS. Salespeople for Bayer unit Berlex Laboratories Inc., acquired in the 2006 purchase of Schering AG, received an e-mail that year from a company official citing a Woman’s Day magazine article about Yaz.

Phoenix Attorney Van O’Steen has asked the federal Food and Drug Administration (FDA) to ban Yaz, Yasmin and all other birth control pills containing the progestin drospirenone. O’Steen’s law firm, O’Steen & Harrison, PLC, represents patients throughout the United States who have been seriously harmed by Bayer Healthcare’s top selling contraceptive medications.

The blockbuster birth control pill with benefits, Yaz was pitched as the choice for women desperate for relief from severe PMS and acne. But now, new independent studies have found that Yaz carries higher blood clotting risks than other leading birth control pills.

The New Jersey judiciary is considering a request from Passaic County, N.J.'s top judge for mass tort status for a growing number of suits alleging strokes and other serious health problems from the oral contraceptives Yaz, Yasmin and Ocella.

With 13 suits filed in his vicinage, Assignment Judge Donald Volkert Jr. wrote to Acting Administrative Director of the Courts Glenn Grant on Oct. 22 that "the case management and potential trial of this particular litigation would place a fairly substantial strain on our already limited resources."

Bayer AG, Germany’s largest drugmaker, was sued by two Pennsylvania pension funds and accused of misrepresenting the safety and effectiveness of the Yaz contraceptive to boost sales.

Bayer unlawfully promoted the drug from March 2006 to March 2009 by concealing side effects including blood clots, heart attacks and pulmonary embolisms, two health and welfare funds for firefighters and city employees said in a federal court complaint made public today in Philadelphia.

Bayer AG, Germany’s largest drugmaker, said its Yaz contraceptive is part of an investigation by a Swiss health regulator into the death of a young woman who took the pill.

The Swissmedic agency and an investigative judge are looking into the case of the woman, who died from the effects of pulmonary embolism, Bayer’s Swiss health unit said in a statement posted on its Web site yesterday. Bayer is cooperating with the authorities, the company said.

After a birth control pill spent months in the spotlight during commercials aimed at correcting misrepresentations about it, the pill is now at the center of a St. Clair County lawsuit.

Kerry Sims filed a lawsuit Aug. 18 against Bayer and Walgreens, alleging her ingestion of the birth control pill Yasmin, which is also known as Yaz, caused her to experience a blood clot in her lung and infection surrounding the clot.

O'Steen & Harrison, PLC

300 W. Clarendon Ave., Suite 400
Phoenix, Arizona 85013-3424

800.883.8888
info@vanosteen.com

Your Legal Rights

If you or a loved one has been experienced side effects after taking Yaz, Yasmin or Ocella, you may be entitled to compensation.

You should act immediately to contact a lawyer experienced in matters involving dangerous pharmaceuticals.

Contact Us